#United States #Belgrade #Xtant Medical #nanOss Strata #Synthetic Bone Graft

Xtant Medical Introduces nanOss Strata™: A Revolutionary Synthetic Bone Graft

Xtant Medical Holdings, Inc., a prominent player in the medical technology sector, has officially launched its latest product, the nanOss Strata™ synthetic bone graft. This groundbreaking innovation is set to revolutionize the way orthopedics address bone grafting, particularly in spinal and orthopedic surgeries.

A Closer Look at nanOss Strata™

Manufactured using hydroxycarbonapatite (HCA), the nanOss Strata sets itself apart from conventional synthetic materials like hydroxyapatite (HA) due to its higher solubility. This unique quality enhances the bioactivity of the graft, facilitating better integration and adaptation with the body’s natural bone tissue during the healing phase.

The nanocrystalline composition of HCA is meticulously designed to replicate human bone structure. This structural similarity enhances the surface area and promotes osteoconductivity, encouraging increased cellular activity at the graft site post-implantation. The introduction of these features marks a significant advancement in regenerative medicine, improving outcomes for patients undergoing surgical procedures.

Versatile Application Options

Xtant Medical offers the nanOss Strata in two convenient formats: compression-resistant preformed strips and prehydrated moldable grafts. Both variants are sterile and designed for quick absorption of blood and other biological fluids, making them suitable for various surgical settings. Surgeons can easily manipulate the grafts to fit the specific needs of their patients, providing more individualized care.

Sean Browne, President and CEO of Xtant Medical, highlighted the significance of this launch: "Building upon the clinical success of our previous nanOss products, Strata showcases our dedication to innovation within the field of regenerative medicine. We are thrilled to present this advanced technology, aimed at enhancing surgical outcomes and improving the overall patient experience."

Accessibility and Distribution

The nanOss Strata is now available through Xtant Medical's comprehensive nationwide distribution network. Healthcare providers can readily access this state-of-the-art graft, ensuring that more patients benefit from the latest advancements in orthopedic surgical solutions.

Conclusion

With the introduction of the nanOss Strata™, Xtant Medical reaffirms its position as a leader in medical technology innovation. The company’s unwavering commitment to advancing healthcare solutions continues to pave the way for improved patient care and surgical efficacy. As this product enters the market, it holds the potential to significantly alter the landscape of orthopedic surgery, promising better recovery outcomes for countless patients. For more information on the nanOss Strata and other offerings, visit Xtant Medical.